Lee Ainslie Danaher Corp Transaction History

Maverick Capital LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $15.3 Million - $17.4 Million	-67,921 Reduced 23.57%	220,195 $55 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $26.6 Million - $33.5 Million	143,658 Added 99.45%	288,116 $66.7 Million
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $1.86 Million - $2.11 Million	-7,962 Reduced 5.22%	144,458 $35.8 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $33.8 Million - $38.5 Million	150,164 Added 6656.21%	152,420 $36.6 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $540,876 - $624,912	2,256 New	2,256 $568,000
Q1 2021 May 17, 2021	SELL	$212.38 - $245.9 $749,701 - $868,027	-3,530 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $750,125 - $866,473	3,530 New	3,530 $784,000
Q3 2020 Nov 16, 2020	SELL	$177.16 - $215.33 $261,488 - $317,827	-1,476 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$128.7 - $176.83 $189,961 - $261,001	1,476 New	1,476 $261,000

2,507

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $170B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.